Tag: CLEAR study

Vesalio announces presentation of positive CLEAR study results at ESMINT 2023

Vesalio has announced the recent presentation of key findings from the CLEAR study—a prospective, multicentre, open-label, single-arm, US Food and Drug Administration (FDA)-regulated investigational...
vesalio

Vesalio announces completion of enrolment in acute ischaemic stroke IDE study

Vesalio has announced the completion of patient enrolment for the CLEAR US Food and Drug Administration (FDA) investigational device exemption (IDE) study utilising the NeVa...